ClinicalTrials.Veeva

Menu

Barrier Function and Production of Inflammatory Cytokines in the Rectal Mucosa in Patients With Septic Shock

H

Herlev Hospital

Status

Unknown

Conditions

Septic Shock

Treatments

Procedure: Measurement of inflammatory markers in the rectal mucosa
Procedure: Rectal biopsy
Procedure: Measurement of rectal lactic acid

Study type

Observational

Funder types

Other

Identifiers

NCT00378586
KA-05037

Details and patient eligibility

About

Life-threatening infection impairs bloodflow to the gut, thereby causing less delivery of oxygen. This leads to increased formation of different inflammatory and infectious markers.

The investigators hypothesize, therefore, that there is a significant difference in the concentrations of inflammatory and infectious markers in the rectal mucosa between patients with septic shock and healthy controls.

Enrollment

30 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Septic shock

Exclusion criteria

  • Age < 18 years
  • No next of kin
  • Pathology of the descending or sigmoid colon or rectum
  • Pregnancy
  • 1st degree relatives with inflammatory bowel disease
  • Severe coagulopathy

Trial contacts and locations

1

Loading...

Central trial contact

Michael Ibsen, MD; Anders Perner, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems